Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2467443018 | Oral naratriptan (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2473600018 | Oral naratriptan | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2757967010 | Oral form naratriptan (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2773856010 | Oral form naratriptan | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3486826013 | Product containing naratriptan in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495188019 | Product containing naratriptan in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495189010 | Naratriptan in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3710975018 | Naratriptan-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3710976017 | Product containing naratriptan in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing naratriptan in oral dose form (medicinal product form) | Is a | Product containing naratriptan | true | Inferred relationship | Existential restriction modifier | ||
| Product containing naratriptan in oral dose form (medicinal product form) | Has active ingredient | Naratriptan | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing naratriptan in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing naratriptan in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing naratriptan in oral dose form (medicinal product form) | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet | Is a | False | Product containing naratriptan in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely naratriptan hydrochloride 1 milligram/1 each conventional release oral tablet | Is a | False | Product containing naratriptan in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only naratriptan in oral dose form (medicinal product form) | Is a | True | Product containing naratriptan in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR